Brief: ImmunoPrecise Antibodies posts Q1 revenue CAD 5.7 million
14/09/2023 13:57
Sep 14 (Reuters) - ImmunoPrecise Antibodies Q1 revenue CAD 5.7 million
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai